Full Press Release Details
CRISPR Therapeutics to Participate in the Canaccord Genuity 41st Annual Growth Conference.
CRSP
CRISPR Therapeutics to Participate in the Canaccord Genuity 41st Annual Growth Conference
Key Takeaway: CRISPR Therapeutics to Participate in the Canaccord Genuity 41st Annual Growth Conference
Price reaction · baseline $124.61 (2021-08-04 close) · hit after-hours · clean, no other CRSP news in the window
day 0 close
+7.1%
day 1 · peak
+9.7%
day 3
+8.5%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+60%
120-day peak, hindsight
Typical move
2.4%
average across 2 past catalysts
Cash runway
~84 mo
Minimal dilution risk
Lead asset
CTX340
Phase 1 · Hypertension